Does UPADACITINIB Cause Post procedural haemorrhage? 26 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Post procedural haemorrhage have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.
26
Reports of Post procedural haemorrhage with UPADACITINIB
0.0%
of all UPADACITINIB reports
1
Deaths
12
Hospitalizations
How Dangerous Is Post procedural haemorrhage From UPADACITINIB?
Of the 26 reports, 1 (3.8%) resulted in death, 12 (46.2%) required hospitalization.
Is Post procedural haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Post procedural haemorrhage?
LEVONORGESTREL (1,106)
RIVAROXABAN (930)
ASPIRIN (618)
APIXABAN (539)
ADALIMUMAB (476)
IBRUTINIB (269)
CLOPIDOGREL BISULFATE (235)
HEPARIN (174)
WARFARIN (170)
DABIGATRAN ETEXILATE (121)
Which UPADACITINIB Alternatives Have Lower Post procedural haemorrhage Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL